Cargando…
Functional characterization of TSPAN7 as a novel indicator for immunotherapy in glioma
Glioma is the most common primary malignant tumor of the central nervous system in clinical practice. Most adult diffuse gliomas have poor efficacy after standard treatment, especially glioblastoma. With the in-depth understanding of brain immune microenvironment, immunotherapy as a new treatment ha...
Autores principales: | Chen, Long, Liu, Hongwei, Li, Yanwen, Lin, Xuelei, Xia, Shunjin, Wanggou, Siyi, Li, Xuejun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947846/ https://www.ncbi.nlm.nih.gov/pubmed/36845098 http://dx.doi.org/10.3389/fimmu.2023.1105489 |
Ejemplares similares
-
Immune Infiltration Associated MAN2B1 Is a Novel Prognostic Biomarker for Glioma
por: Lin, Xuelei, et al.
Publicado: (2022) -
Transcription factor ZBTB42 is a novel prognostic factor associated with immune cell infiltration in glioma
por: Li, Yanwen, et al.
Publicado: (2023) -
Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy
por: Teng, Chubei, et al.
Publicado: (2022) -
Identification of the novel prognostic biomarker, MLLT11, reveals its relationship with immune checkpoint markers in glioma
por: Chen, Long, et al.
Publicado: (2022) -
Survival Risk Prediction Models of Gliomas Based on IDH and 1p/19q
por: Zou, Han, et al.
Publicado: (2020)